Cited by 18Biotin and Related StudiesHER2/EGFR in Cancer ResearchProtein Degradation and Inhibitors

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Proximity extracellular protein-protein interaction analysis of EGFR using AirID-conjugated fragment of antigen binding

Open access

Published version of a preprint

Abstract

Receptor proteins, such as epidermal growth factor receptor (EGFR), interact with other proteins in the extracellular region of the cell membrane to drive intracellular signalling. Therefore, analysis of extracellular protein-protein interactions (exPPIs) is important for understanding the biological function of receptor proteins. Here, we present an approach using a proximity biotinylation enzyme (AirID) fusion fragment of antigen binding (FabID) to analyse the proximity exPPIs of EGFR. AirID was C-terminally fused to the Fab fragment against EGFR (EGFR-FabID), which could then biotinylate the extracellular region of EGFR in several cell lines. Liquid Chromatography-Mass Spectrometry (LC-MS/MS) analysis indicated that many known EGFR interactors were identified as proximity exPPIs, along with many unknown candidate interactors, using EGFR-FabID. Interestingly, these proximity exPPIs were influenced by treatment with EGF ligand and its specific kinase inhibitor, gefitinib. These results indicate that FabID provides accurate proximity exPPI analysis of target receptor proteins on cell membranes with ligand and drug responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-023-43931-7

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 57

  1. Bechtel, T. J. et al. Strategies for monitoring cell–cell interactions. Nat. Chem. Biol. 17, 641–652 (2021). · DOI
  2. Bausch-Fluck, D. et al. The in silico human surfaceome. Proc. Natl. Acad. Sci. USA 115, E10988–E10997 (2018). · DOI
  3. Yin, H. & Flynn, A. D. Drugging membrane protein interactions. Annu Rev. Biomed. Eng. 18, 51–76 (2016). · DOI
  4. Zhao, S. et al. Screening and identification of host proteins interacting with Theileria annulata cysteine proteinase (TaCP) by yeast-two-hybrid system. Parasite Vectors 10, 536 (2017). · DOI
  5. Li, J. et al. Development of a membrane-anchored ligand and receptor yeast two-hybrid system for ligand-receptor interaction identification. Sci. Rep. 6, 35631 (2016). · DOI
  6. Ohshiro, K. et al. Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator. Mol. Endocrinol. 24, 914–922 (2010). · DOI
  7. Han, J. et al. The identification of novel protein-protein interactions in liver that affect glucagon receptor activity. PLoS One. 10, e0129226 (2015). · DOI
  8. Nemoto, K. et al. Tyrosine phosphorylation of the GARU E3 ubiquitin ligase promotes gibberellin signalling by preventing GID1 degradation. Nat. Commun. 8, 1004 (2017). · DOI
  9. Takahashi, H. et al. Establishment of a wheat cell-free synthesized protein array containing 250 human and mouse e3 ubiquitin ligases to identify novel interaction between e3 ligases and substrate proteins. PLoS One. 11, e0156718 (2016). · DOI
  10. Geri, J. B. et al. Microenvironment mapping via Dexter energy transfer on immune cells. Science 367, 1091–1097 (2020). · DOI · Paper page
  11. Oakley, J. V. et al. Radius measurement via super-resolution microscopy enables the development of a variable radii proximity labeling platform. Proc. Natl. Acad. Sci. USA 119, e2203027119 (2022). · DOI
  12. Bosch, J. A., Chen, C. L. & Perrimon, N. Proximity-dependent labeling methods for proteomic profiling in living cells: an update. Wiley interdiscip. Rev. Dev. Biol. 10, e392 (2020). · DOI
  13. Kim, D. I. et al. Probing nuclear pore complex architecture with proximity-dependent biotinylation. Proc. Natl. Acad. Sci. USA 111, 2453–2461 (2014). · DOI · Paper page
  14. Go, C. D. et al. A proximity-dependent biotinylation map of a human cell. Nature 595, 120–124 (2021). · DOI
  15. Varnaitė, R. & MacNeill, S. A. Meet the neighbors: mapping local protein interactomes by proximity-dependent labeling with BioID. Proteomics 16, 2503–2518 (2016). · DOI · Paper page
  16. Samavarchi-Tehrani, P., Samson, R. & Gingras, A. C. Proximity dependent biotinylation: key enzymes and adaptation to proteomics approaches. Mol. Cell. Proteom. 19, 757–773 (2020). · DOI
  17. Ge, Y. et al. Enzyme-mediated intercellular proximity labeling for detecting cell-cell interactions. J. Am. Chem. Soc. 141, 1833–1837 (2019). · DOI
  18. Liu, Q. et al. A proximity-tagging system to identify membrane protein-protein interactions. Nat. Methods 15, 715–722 (2018). · DOI
  19. Martell, J. D. et al. Engineered ascorbate peroxidase as a genetically encoded reporter for electron microscopy. Nat. Biotechnol. 30, 1143–1148 (2012). · DOI · Paper page
  20. James, C. et al. Proteomic mapping by rapamycin-dependent targeting of APEX2 identifies binding partners of VAPB at the inner nuclear membrane. J. Biol. Chem. 294, 16241–16254 (2019). · DOI
  21. Choi-Rhee, E., Schulman, H. & Cronan, J. E. Promiscuous protein biotinylation by Escherichia coli biotin protein ligase. Protein Sci. 13, 3043–3050 (2004). · DOI
  22. Branon, T. C. et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat. Biotechnol. 36, 880–887 (2018). · DOI · Paper page
  23. Roux, K. J. et al. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J. Cell Biol. 196, 801–810 (2012). · DOI · Paper page
  24. Kido, K. et al. AirID, a novel proximity biotinylation enzyme, for analysis of protein–protein interactions. eLife 9, e54983 (2020). · DOI
  25. Yamanaka, S. et al. A proximity biotinylation-based approach to identify protein-E3 ligase interactions induced by PROTACs and molecular glues. Nat. Commun. 13, 183 (2022). · DOI
  26. Shafraz, O. et al. Mapping transmembrane binding partners for E-cadherin ectodomains. Proc. Natl. Acad. Sci. Usa. 117, 31157–31165 (2020). · DOI
  27. Dhillon, S. Gefitinib: a review of its use in adults with advanced non-small cell lung cancer. Target. Oncol. 10, 153–170 (2015). · DOI
  28. Yano, T. et al. AGIA tag system based on a high affinity rabbit monoclonal antibody against human dopamine receptor D1 for protein analysis. PLoS One. 11, e0156716 (2016). · DOI
  29. Gerweck, L. E. & Seetharaman, K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 56, 1194–1198 (1996).
  30. Talukdar, S. et al. EGFR: an essential receptor tyrosine kinase-regulator of cancer stem cells. Adv. Cancer Res. 147, 161–188 (2020). · DOI
  31. Freed, D. M. et al. EGFR ligands differentially stabilize receptor dimers to specify signaling kinetics. Cell 171, 683–695.e18 (2017). · DOI
  32. Foerster, S. et al. Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics. Proteomics 13, 3131–3144 (2013). · DOI
  33. Thelemann, A. et al. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells. Mol. Cell. Proteom. 4, 356–376 (2005). · DOI
  34. Kaneko, M. K. et al. Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134. Biochem. Biophys. Rep. 14, 54–57 (2018).
  35. Itai, S. et al. Establishment of EMab-134, a sensitive and specific anti-epidermal growth factor receptor monoclonal antibody for detecting squamous cell carcinoma cells of the oral cavity. Monoclon. Antib. Immunodiagn. Immunother. 36, 272–281 (2017). · DOI
  36. Ogiso, H. et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775–787 (2002). · DOI
  37. Garrett, T. P. J. et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α. Cell 110, 763–773 (2002). · DOI
  38. Motani, K. & Kosako, H. Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D. J. Biol. Chem. 293, 7717–7726 (2018). · DOI
  39. Nishino, K. et al. Optimized workflow for enrichment and identification of biotinylated peptides using tamavidin 2-REV for BioID and cell surface proteomics. J. Proteome Res. 21, 2094–2103 (2022). · DOI
  40. Krogh, A. et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305, 567–580 (2001). · DOI · Paper page
  41. Hermjakob, H. et al. IntAct: an open source molecular interaction database. Nucleic Acids Res. 32, D452–D455 (2004). · DOI
  42. Carpenter, G., King, L. & Cohen, S. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature 276, 409–410 (1978). · DOI
  43. Hua, Q. et al. AL355338 acts as an oncogenic lncRNA by interacting with protein ENO1 to regulate EGFR/AKT pathway in NSCLC. Cancer Cell Int. 21, 525 (2021). · DOI
  44. Itagaki, K. et al. Eukaryotic translation elongation factor 1A induces anoikis by triggering cell detachment. J. Biol. Chem. 287, 16037–16046 (2012). · DOI
  45. Kobayashi, S. et al. EGFR mutation and resistance of non–small-cell lung cancer to Gefitinib. N. Engl. J. Med. 352, 786–792 (2005). · DOI · Paper page
  46. Cui, N. P. et al. Protein Tyrosine Kinase 7 Regulates EGFR/Akt signaling pathway and correlates with malignant progression in triple-negative breast cancer. Front. Oncol. 11, 699889 (2021). · DOI
  47. Stefani, C. et al. Growth dactors, PI3K/AKT/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: Where Are We Now? Int J. Mol. Sci. 22, 10260 (2021). · DOI · Paper page
  48. Wang, Y. P. et al. Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma. Cancer Lett. 337, 96–106 (2013). · DOI
  49. Zunke, F. & Rose-John, S. The shedding protease ADAM17: physiology and pathophysiology. Biochim. Biophys. Acta Mol. Cell Res. 1864, 2059–2070 (2017). · DOI
  50. Scapin, G. et al. Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. Nature 556, 122–125 (2018). · DOI
  51. Kotani, N. et al. Biochemical visualization of cell surface molecular clustering in living cells. Proc. Natl. Acad. Sci. USA 105, 7405–7409 (2008). · DOI
  52. Kotani, N. et al. Proximity proteomics identifies cancer cell membrane cis-molecular complex as a potential cancer target. Cancer Sci. 110, 2607–2619 (2019). · DOI
  53. Kumagai, S., Koyama, S. & Nishikawa, H. Antitumour immunity regulated by aberrant ERBB family signalling. Nat. Rev. Cancer 21, 187–197 (2021). · DOI
  54. Sawasaki, T., Ogasawara, T., Morishita, R. & Endo, Y. A cell-free protein synthesis system for high-throughput proteomics. Proc. Natl. Acad. Sci. USA 99, 14652–14657 (2002). · DOI
  55. Nagase, T. et al. Exploration of human ORFeome: high-throughput preparation of ORF clones and efficient characterization of their protein products. DNA Res. 15, 137–149 (2008). · DOI
  56. Berrow, N. S. et al. A versatile ligation-independent cloning method suitable for high-throughput expression screening applications. Nucleic Acids Res. 35, e45 (2007). · DOI
  57. Law, A. M. K. et al. Andy’s Algorithms: new automated digital image analysis pipelines for FIJI. Sci. Rep. 7, 15717 (2017). · DOI

Metadata

Authors
Yamada, K., Shioya, R., Nishino, K., Furihata, H., Hijikata, A., Kaneko, M. K., Kato, Y., Shirai, T., Kosako, H., & Sawasaki, T.
Affiliations
  • Ehime University (JP)
  • Institute of Advanced Medical Sciences, Tokushima University (JP)
  • Tokyo University of Pharmacy and Life Sciences (JP)
  • Tohoku University (JP)
  • Nagahama Institute of Bio-Science and Technology (JP)
Corresponding author
  • Kosako, Hidetaka
  • Sawasaki, Tatsuya
Venue
Nature Communications
Published
2023-12-14
Volume
14
Issue
1
Pages
8301-8301
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4389738380
Cited by
18
References
2
Citations by year
2026: 9 · 2025: 6 · 2024: 3
FWCI
2.60
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (acceptedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Japan Agency for Medical Research and Development (JP21am0101077, 22ama121010j0001, 23ama121010j0002, JP22ama121008)
  • MEXT | Japan Society for the Promotion of Science (19H03218, JP21K19230)
  • Takeda Science Foundation
  • Joint Usage and Joint Research Programs of the Institute of Advanced Medical Sciences, Tokushima University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Biotin and Related Studies
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
Keywords
epidermal growth factor receptor, proximity biotinylation, receptor signaling, EGF ligands, gefitinib, kinase inhibitors, protein-protein interaction network
MeSH terms
Chromatography, Liquid, Epidermal Growth Factor, Ligands, Phosphorylation, Tandem Mass Spectrometry, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review